BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15744170)

  • 41. Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome.
    Bhide SA; Ahmed M; Rengarajan V; Powell C; Miah A; Newbold K; Nutting CM; Harrington KJ
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):391-8. PubMed ID: 18692326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Head and neck squamous and thyroid carcinomas: multiplexed Luminex approaches for early detection.
    Linkov F; Stack B; Yurkovetsky Z; Poveda S; Lokshin A; Ferris RL
    Expert Opin Med Diagn; 2007 Sep; 1(1):129-36. PubMed ID: 23489275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
    Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
    J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck.
    Wei Q; Wang LE; Sturgis EM; Mao L
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1961-6. PubMed ID: 16103444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum perioperative profile of cytokines in patients with squamous cell carcinoma of the larynx.
    Melinceanu L; Lerescu L; Tucureanu C; Caras I; Pitica R; Sarafoleanu C; Salageanu A
    J Otolaryngol Head Neck Surg; 2011 Apr; 40(2):143-50. PubMed ID: 21453650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma.
    Pries R; Thiel A; Brocks C; Wollenberg B
    In Vivo; 2006; 20(1):45-8. PubMed ID: 16433027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
    Gourin CG; Zhi W; Adam BL
    Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum circulating human mRNA profiling and its utility for oral cancer detection.
    Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT
    J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
    Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene profiling in squamous cell carcinoma of the head and neck.
    Akervall J
    Cancer Metastasis Rev; 2005 Jan; 24(1):87-94. PubMed ID: 15785874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
    Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.
    Jaglowski JR; Zagon IS; Stack BC; Verderame MF; Leure-duPree AE; Manning JD; McLaughlin PJ
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):97-104. PubMed ID: 15791460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck.
    Li D; Wang LE; Chang P; El-Naggar AK; Sturgis EM; Wei Q
    Cancer Res; 2007 Jun; 67(12):5628-34. PubMed ID: 17575128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
    An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer.
    Caballero M; Grau JJ; Blanch JL; Domingo-Domenech J; Auge JM; Jimenez W; Bernal-Sprekelsen M
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1143-8. PubMed ID: 18025320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarker profile in off-pump and on-pump coronary artery bypass grafting surgery in low-risk patients.
    Castellheim A; Hoel TN; Videm V; Fosse E; Pharo A; Svennevig JL; Fiane AE; Mollnes TE
    Ann Thorac Surg; 2008 Jun; 85(6):1994-2002. PubMed ID: 18498809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum cytokine and chemokine profiles in neonates with meconium aspiration syndrome.
    Okazaki K; Kondo M; Kato M; Kakinuma R; Nishida A; Noda M; Taniguchi K; Kimura H
    Pediatrics; 2008 Apr; 121(4):e748-53. PubMed ID: 18346989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.